NFATC1 and posterior cortical atrophy: Likewise, EVs derived from bone metastatic PCa were enriched with miR-378a-3p in patient serum, PC-3, and C4-2B cell lines, promoting osteolytic progression through activation of the DYRK1a/NFATC1/ANGPTL2 pathway [241].